iAnthus Reports First Quarter 2025 Financial Results NEW YORK and TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the first quarter ended March 31, 2025. The Company’s Quarterly Report on Form 10-Q (the “Quarterly Report”), which includes its unaudited interim condensed consolidated financial statements for the first quarter ended March 31, 2025 and the related management’s d...
iAnthus Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results NEW YORK and TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the fourth quarter and year ended December 31, 2024. The Company’s Annual Report on Form 10-K (the “Annual Report”), which includes its audited consolidated financial statements for the year ended December 31, 2024 and the related managemen...
iAnthus Expands Presence in Florida with New GrowHealthy Dispensary in Jacksonville The 21st dispensary enhances patient access to premium medical cannabis with interactive product displays and a commitment to community engagement NEW YORK and TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, has announced the opening of its first GrowHealthy dispensary in Jacksonville, Florida, it’s 21st statewide. “This opening h...
iAnthus Strengthens Portfolio with $36.5M Sale of Select Arizona Assets to Sonoran Roots Transaction Supports iAnthus' Focus on Key Growth Markets While Maintaining Presence in Arizona NEW YORK and TORONTO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, today announced that certain iAnthus subsidiaries entered into definitive agreements (the “Purchase Agreements”) with a leading Arizona cannabis operator, Pitchfork Enterp...
iAnthus Announces Strategic Partnership with Grön Edibles to Bring an Innovative Women Owned Edible Brand to New Jersey NEW YORK and TORONTO, Jan. 09, 2024 (GLOBE NEWSWIRE) -- (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), a leading national cannabis consumer packaged goods company and owner of MPX-NJ dispensaries in New Jersey, announces a strategic partnership to bring Grön, the renowned, woman-owned producer of handcrafted cannabis-infused edibles to the New Jersey market. This collaboration marks a significant step in ensuring New Jersey consumers have access to the world’s m...
A director at Ianthus Capital Holdings Inc bought 2,000,000 shares at 0.019USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
IANTHUS - SELL | CAD0.01(-97%) Capital restructuring mocks existing shareholders The root cause is disappointing management Plan of Arrangements offers existing shareholders a 2.75% stake And debt goes down to CAD121.4m from CAD168.7m – that is all Just in case you were wondering who came up with the idea…
FLOWR - BUY | CAD1.2(+97%) Feedback from virtual meeting From recreational in Canada to medical cannabis in Europe High THC products is what recreational consumer want Nearing cash flow break-even The latest capital raising should be the last one
FLOWR - BUY | CAD1.2 vs. CAD1.9 (+107%) The second half is nearly there Focus on premium recreational Canadian market CAD20m convertible raise led by insiders Terrace deal to finance start of production in Portugal Results recap and new forecasts
Initiation of Coverage | FLOWR | “La Vie en Rose†| BUY, CAD3.5 Flowr is a Canadian and European Licensed Cannabis Producer differentiated with on the one hand exposure to the premium end of the Canadian recreational cannabis market and on the other hand large scale low-cost cultivation in Portugal for the European and global medical cannabis market under EU-GMP certification. We are initiating the company with a Buy rating and a fair value of CAD3.3 per share.
Cannabis Q3 results could trigger further share price weakness Harmonizing valuations downward Concern no 1: Persistent losses at larger operators Concern no 2: Weak Q3 CY19 due to inventory build-up Concern no 3: Vaping health issues to impact US MSO and potentially delay Canadian introduction
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.